Procurement Summary
Country: USA
Summary: Progenesis Qi Software Acquisition
Deadline: 25 May 2026
Posting Date: 15 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141318396
Document Ref. No.: FDA-75F40126Q00143
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Contractor shall provide one (1) commercial perpetual software license for Progenesis QI Software License. The scope includes delivery of the software, activation credentials, and applicable commercial documentation. This acquisition does not include system development, hosting services, contractor access to FDA systems, or ongoing managed services.
Notice ID: fda-75f40126q00143
Department/Ind. Agency: health and human services, department of
Sub-tier: food and drug administration
Office: fda office of acq grant svcs
Product Service Code: da10 - it and telecom - business application/application development software as a service
NAICS Code: 5132 - Software Publishers
Inactive Dates: jun 09, 2026
Inactive Policy: 15 days after date offers due
Documents
Tender Notice
Documents.zip